You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Handoff Training for Combat Casualty Care (HTC3) Framework

    SBC: Perceptronics Solutions, Inc.            Topic: DHA17B001

    This proposal is to develop a Handoff Training for Combat Casualty Care (HTC3) Framework.Training is the crux of the handoff problem today. Patient handoffs are a crucial part of casualty care, both in military and civilian environments; and today handoffs are being performed in less than optimal fashion, with ineffective communications accounting for 80% of the handoff errors. Our new HTC3 Framew ...

    STTR Phase I 2018 Department of DefenseDefense Health Agency
  2. Human Performance Optimization: Ketone Esters for Optimization of Operator Performance in Hypoxia

    SBC: HVMN Inc.            Topic: SOCOM17C001

    In the setting of altitude-induced hypoxia, operator cognitive capacity degrades and can compromise both individual and team performance. This degradation is linked to falling brain energy (ATP) levels and an increased reliance on anaerobic energy production from glucose. Ketone bodies are the evolutionary alternative substrate to glucose for brain metabolic requirements; previous studies have sho ...

    STTR Phase I 2018 Department of DefenseSpecial Operations Command
  3. Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point ofCare Applications

    SBC: GENECAPTURE            Topic: CBD15C001

    GeneCapture, Inc. is proposing to develop a rapid in vitro diagnostic prototype using our patented molecular-based CAPTURE (ConfirmActive Pathogens Through Unamplified RNA Expression) assay. Based on the results and experience gained in our Phase I STTR contractHDTRA1-16C-0061: Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications, we p ...

    STTR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense
  4. In-Mask Sensors for Physiological Investigation of Respiratory Exhalation- INSPIRE

    SBC: MAKEL ENGINEERING, INC.            Topic: DHP16C002

    Makel Engineering, Inc. and Sandia National Laboratories propose to demonstrate an advanced multi-modal sensor system suitable for in-situ analysis of exhaled VOCs for pilots, divers and field patients. Our proposed system will combine a micro-gas chromatograph (GC) and miniature ion mobility spectrometer (IMS) for detection of trace amounts of exhaled breath VOCs with miniature solid state sensor ...

    STTR Phase I 2017 Department of DefenseDefense Health Agency
  5. INSPIRE- In-Mask Sensors for Physiological Investigation of Respiratory Exhalation

    SBC: MAKEL ENGINEERING, INC.            Topic: DHP16C002

    Makel Engineering, Inc. and Sandia National Laboratories propose to demonstrate an advanced multi-modal sensor system for in-situ analysis of exhaled volatile organic compounds (VOCs) for pilots, divers and field patients. The In-Mask Sensors for Physiological Investigation of Respiratory Exhalation – INSPIRE combines a micro-gas chromatograph (?GC) and miniature ion mobility spectrometer (IMS) ...

    STTR Phase II 2018 Department of DefenseDefense Health Agency
  6. Marburg Virus Prophylactic Medical Countermeasure

    SBC: MAPP BIOPHARMACEUTICAL, INC.            Topic: CBD18A002

    There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terriblemorbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditionalvaccines have proven to be a huge contribution to public health, they do have some limitations especially in the cont ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  7. Marburg Virus Prophylactic Medical Countermeasure

    SBC: Flow Pharma, Inc.            Topic: CBD18A002

    Flow Pharma, Inc. is a biotechnology company in the San Francisco Bay Area developing fully synthetic cytotoxic T lymphocyte (CTL)stimulating peptide vaccines for Marburg virus. The FlowVax vaccine platform allows us to create dry powder formulations of biodegradablemicrospheres and TLR adjuvants incorporating class I and class II T cell epitopes. FlowVax vaccines can be designed for delivery by i ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  8. Mask integrated Volatile Organic Compound (VOC) sensor for real-time warfighter physiological status monitoring in extreme and toxic environments

    SBC: Bayspec, Inc.            Topic: DHP16C002

    BaySpec Inc., in collaboration with Pacific Northwest National Laboratory, proposes to develop an innovative orthogonal sensor systemthat would be able to detect, identify and quantify the inorganic components of breathing mixes, (i.e., nitrogen, oxygen, carbon dioxide, argon, helium, and water vapor), as well as individual detectable VOCs within the exhaled breath in real-time. The Phase I resear ...

    STTR Phase I 2017 Department of DefenseDefense Health Agency
  9. Multimodal imaging system for burn injury assessment

    SBC: UTOPIACOMPRESSION,CORPORATION            Topic: DHP16C005

    The goal of this STTR effort is to design a portable, multimodal, non-contact imaging system for burn depth diagnosis and tracking of wound healing. UC and Vanderbilt University will build upon our previous efforts demonstrated via porcine model studies to combine results from structural B-mode optical coherence tomography (OCT) images and functional data (pulse speckle imaging- PSI) to classify d ...

    STTR Phase I 2017 Department of DefenseDefense Health Agency
  10. Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases

    SBC: CFD Research Corporation            Topic: CBD18A001

    In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens,whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial andalphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable and ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government